ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 80003610228

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610228 and manufactured by INOVA DIAGNOSTICS , INC.. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80003610228
Registration Details
ANVISA Registration Number: 80003610228
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

QUANTA Lite™ h-tTG (Transglutaminase do tecido humano) IgG ELISA
Risk Class II

Registration Details

80003610228

25351871857200889

02004662000165

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 24, 2009

VIGENTE

09/18/2025 19:00:01